异甘草酸镁注射液与注射用还原型谷胱甘肽配伍的稳定性分析

李晓晖; 文娱; 晋文慧; 洪专; 曾美燕; 陈伟珠

doi:10.3969/j.issn.1001-5256.2016.01.028

异甘草酸镁注射液与注射用还原型谷胱甘肽配伍的稳定性分析

DOI: 10.3969/j.issn.1001-5256.2016.01.028

1. 厦门市中医院药物临床试验机构
2. 厦门市中医院药剂科
3. 国家海洋局第三海洋研究所

基金项目:

福建中医药大学2014年校管课题(XB2014050)；

详细信息

中图分类号: R969.2
计量
- 文章访问数: 3358
- HTML全文浏览量: 23
- PDF下载量: 430
- 被引次数: 0
出版历程
- 收稿日期: 2015-05-07
- 出版日期: 2016-01-20

Compatible stability of magnesium isoglycyrrhizinate injection and reduced glutathione for injection

Drug Clinical Trial Institution,Xiamen Hospital of Traditional Chinese Medicine

Research funding:

摘要

摘要:
目的考察异甘草酸镁(MgIG)注射液与注射用还原型谷胱甘肽(GSH)在室温条件下配伍的稳定性。方法采用高效液相色谱法测定MgIG注射液与注射用GSH在5%、10%葡萄糖溶液中配伍的浓度变化。结果 MgIG注射液与注射用GSH配伍液在0、0.5、1、1.5、2、4 h内浓度均无明显变化。结论 MgIG注射液与注射用GSH在5%、10%葡萄糖溶液中可以配伍使用,但应在4 h内用完。
- 异甘草酸镁 /
- 谷胱甘肽 /
- 中药配伍 /
- 药物稳定性
Abstract:
Objective To evaluate the compatible stability of magnesium isoglycyrrhizinate( MgIG) injection and reduced glutathione( GSH) for injection at room temperature. Methods High- performance liquid chromatography was applied to measure the changes in the content of MgIG and reduced GSH after MgIG injection and reduced GSH for injection were mixed with 5% or 10% glucose solution. Results There were no significant changes in the content of MgIG and reduced GSH within 0,0. 5,1,1. 5,2,and 4 h after MgIG injection and reduced GSH for injection were mixed with 5% or 10% glucose solution. Conclusion MgIG injection and reduced GSH for injection are compatible in 5% and 10% glucose solutions,but the mixed solution should be used within 4 h.
- magnesium isoglycyrrhizinate /
- glutathione /
- compatibility /
- drug stability

HTML全文

参考文献(11)

[1]WANG P,WU XM.Therapeutic effect of magnesium isoglycyrrhizinate on carbon tetrachloride-induced chronic liver injury in rats[J].Chin J New Drugs Clin Remed,2004,23(12):833-836.(in Chinese)王佩,吴锡铭.异甘草酸镁对大鼠四氯化碳慢性肝损伤的治疗作用[J].中国新药与临床杂志,2004,23(12):833-836.

[2]OU MH.Advances in pharmacological and clinical research on magnesium isoglycyrrhizinate[J].China Pharm,2010,19(15):83-85.(in Chinese)欧明洪.异甘草酸镁药理与临床研究进展[J].中国药业,2010,19(15):83-85.

[3]YUAN PG,ZHANG DZ.Mechanism of action and clinical application of reduced glutathione[J].Drug Eval,2006,3(5):385-390.(in Chinese)袁平戈,张大志.还原型谷胱甘肽的作用机制及临床应用[J].药品评价,2006,3(5):385-390.

[4]HE M,ZHAN M,LIU RM,et al.Systematic review on reduced glutathione in the treatment of drug-induced liver disease[J].China Pharm,2010,21(32):3049-3052.(in Chinese)何梅,占美,柳汝明,等.还原型谷胱甘肽治疗药物性肝病的系统评价[J].中国药房,2010,21(32):3049-3052.

[5]DAI JH,IWATANI Y,ISHIDA T,et al.Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages[J].Immunology,2001,103(2):235-243.

[6]ABE M,AKBAR F,HASEBE A,et al.Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis[J].J Gastroenterol,2003,38(10):962-967.

[7]ZHANG Q,WU P,ZHANG JJ.The protective effect of the 18-αisomer of glycyrrhizic acid in human hepatocytes with chemical injury[J].Chin J Clin Pharmacol Ther,2011,16(12):1357-1360.(in Chinese)张群,吴培,张建军.18-α异构体甘草酸对化学损伤人肝细胞的保护作用[J].中国临床药理学与治疗学,2011,16(12):1357-1360.

[8]CHEN WH,LU LG,ZENG MD,et al.Effect of magnesium isoglycyrrhizinate on the pmI iferation and oxidative stess of rat hepatic stellate cells in virtro[J].Chin J Hepatol,2006,14(6):426-430.(in Chinese)陈尉华,陆伦根,曾民德,等.异甘草酸镁对大鼠肝星状细胞增殖和氧应激的影响[J].中华肝脏病杂志,2006,14(6):426-430.

[9]ZHONG CM,LI ZL,CHEN ZF.Clinical application of reduced glutathione[J].P Clin Med,2010,19(5A):325-328.(in Chinese)钟春梅,李正良,陈泽芳.还原型谷胱甘肽的临床应用[J].临床医药实践,2010,19(5A):325-328.

[10]WANG YX,ZHANG XQ,WAN SZ.Compatible stability of magnesium isoglycyrrhizinate in 6 mixtures[J].Chin J Hosp Pharm,2008,28(20):1801-1803.(in Chinese)王艳霞,张喜全,万顺之.6种配伍液中异甘草酸镁的稳定性[J].中国医院药学杂志,2008,28(20):1801-1803.

[11]ZHOU XQ,FANG J.Stability of reduced glutathione sodium in four different injections[J].China Pharm,2008,19(35):2759-2761.(in Chinese)周学琴,方静.注射用还原型谷胱甘肽钠与4种注射液的配伍稳定性考察[J].中国药房,2008,19(35):2759-2761.

施引文献

资源附件(0)

访问统计